Dr. Dierk Beyer joins Quarton International as Partner and will strengthen the global groups expertise in Biotech, Pharma and Chemicals

September 1, 2017

With more than 20 years of experience in M&A and advisory in Life Sciences, Dr. Dierk Beyer will develop and strengthen Quarton’s global Health Care and Chemicals practices for Pharma, Biotech, and Chemicals clients as well as for Private equity and venture capital funds investing in these industries. In his prior position from 2008 to 2017, Dr. Beyer successfully established TransAct Advisory Services, an M&A advisory business serving Life Sciences clients globally. Following his PhD in Chemistry, he started his career in 1996 in product development at Hoechst AG, then Clariant and moved to The Boston Consulting Group (BCG) two years later, where he focused on advising international clients in the Health Care and Chemicals sectors.

Andreas Kinsky, partner at Quarton International comments: “We are extremely pleased that Dr. Dierk Beyer will strengthen our partnership. With his decades of experience in various capacities in the pharmaceutical and biotechnology environment, he brings a wealth of expertise into a new vertical sector for Quarton.“

Dr. Dierk Beyer will join Quarton’s newest office in Frankfurt am Main, Germany.

Subscribe to newsletter

© 2017 Quarton International.